These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 20814828)
1. Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency. Henneman L; Schneiders MS; Turkenburg M; Waterham HR J Inherit Metab Dis; 2010 Oct; 33(5):625-32. PubMed ID: 20814828 [TBL] [Abstract][Full Text] [Related]
2. Unprenylated RhoA contributes to IL-1β hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity. van der Burgh R; Pervolaraki K; Turkenburg M; Waterham HR; Frenkel J; Boes M J Biol Chem; 2014 Oct; 289(40):27757-65. PubMed ID: 25107911 [TBL] [Abstract][Full Text] [Related]
5. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases. Zhu Y; Casey PJ; Kumar AP; Pervaiz S Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002 [TBL] [Abstract][Full Text] [Related]
6. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency. Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055 [TBL] [Abstract][Full Text] [Related]
7. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency. Politiek FA; Waterham HR Front Immunol; 2021; 12():724991. PubMed ID: 34539662 [TBL] [Abstract][Full Text] [Related]
8. Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. Schneiders MS; Houten SM; Turkenburg M; Wanders RJ; Waterham HR Arthritis Rheum; 2006 Jul; 54(7):2306-13. PubMed ID: 16802371 [TBL] [Abstract][Full Text] [Related]
9. A role for geranylgeranylation in interleukin-1beta secretion. Mandey SH; Kuijk LM; Frenkel J; Waterham HR Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828 [TBL] [Abstract][Full Text] [Related]
11. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency. Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ Front Immunol; 2019; 10():1900. PubMed ID: 31474985 [TBL] [Abstract][Full Text] [Related]
12. Differential effect of simvastatin on various signal transduction intermediates in cultured human smooth muscle cells. Nègre-Aminou P; van Erck M; van Leeuwen RE; Collard JG; Cohen LH Biochem Pharmacol; 2001 Apr; 61(8):991-8. PubMed ID: 11286990 [TBL] [Abstract][Full Text] [Related]
14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347 [TBL] [Abstract][Full Text] [Related]
15. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation. Lee MH; Cho YS; Han YM Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088 [TBL] [Abstract][Full Text] [Related]
16. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009 [TBL] [Abstract][Full Text] [Related]
17. Respiratory deficiency in yeast mevalonate kinase deficient may explain MKD-associate metabolic disorder in humans. Santos MMS; Elsztein C; De Souza RB; Paiva SSL; Silva JA; Crovella S; De Morais MA Curr Genet; 2018 Aug; 64(4):871-881. PubMed ID: 29374778 [TBL] [Abstract][Full Text] [Related]
18. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation. Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518 [TBL] [Abstract][Full Text] [Related]
19. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276 [TBL] [Abstract][Full Text] [Related]